Related Experiment Videos

Further studies on complementation between mutants of Clostridium perfringens

Biken Journal
|June 1, 1981
PubMed

Insights

Clostridium perfringens mutants lacking specific toxins and hemagglutinin were studied. Group B mutants showed defects in multiple toxin and hemagglutinin productions, suggesting shared regulatory pathways.

Area of Science:

  • Microbiology
  • Bacterial Genetics

Background:

  • Clostridium perfringens produces various toxins and hemagglutinin (HA), crucial virulence factors.
  • Genetic regulation of these factors is not fully understood.

Purpose of the Study:

  • To investigate the genetic basis of toxin and HA production in Clostridium perfringens.
  • To characterize mutants deficient in theta-, lambda-, kappa-toxin, and HA.

Main Methods:

  • Isolation and complementation analysis of Clostridium perfringens mutants.
  • Biochemical assays for toxin activity and extracellular enzyme production.
  • Comparison of wild-type and mutant strains (PB6K and CN3870).

Main Results:

  • Mutants were classified into complementation groups A and B for lambda- and HA-deficient strains; kappa-deficient mutants belonged to group A.
  • Group B mutants exhibited pleiotropic defects in theta-, lambda-, kappa-toxin, and HA production.
  • Lambda-toxin was identified as a rennet-like protease.
  • Extracellular enzyme activities (including sialidase) were similar between group B mutants and wild-type strains, indicating separate regulatory mechanisms.

Conclusions:

  • Shared regulatory mechanisms control the production of theta-, lambda-, kappa-toxin, and HA in Clostridium perfringens.
  • These regulatory mechanisms are distinct from those governing the production of other extracellular enzymes.

Related Concept Videos